Skip to main content

Is Your Doctor Using "Measurement-Based Care" to Treat Your Depression?

Measurement-based care is extensively used in medical conditions and involves matching treatment interventions with the outcomes for those treatments. For example, a provider would periodically measure fasting blood glucose or glycosylated hemoglobin in an individual with diabetes to make adjustments to the treatment plan, including medication and lifestyle changes. With healthcare insurance companies, including Medicare, tying reimbursements to healthcare outcomes, measurement-based care is becoming the norm. Measurement-based care fosters self-management by making the individual aware if they are on the right treatment plan or if they need to modify it in collaboration with their provider. Measurement-based care in depression is an algorithmic application of published, accepted, clinical guidelines and consists of four steps (Morris et al., 2012):

Step 1: Screening: Your provider may use one of the several available tools to screen for the presence and the severity of depressive symptoms. The Patient Health Questionnaire-9 (PHQ-9) is commonly used in primary care settings and is both a screening and a diagnostic tool for depression. Other tools such as Generalized Anxiety Disorder-7 (GAD-7) may also be used to screen for co-occurring anxiety. Screening is a brief process and a positive screen leads to a more comprehensive evaluation of symptoms and functional impairment associated with the symptoms.

Step 2: Treatment selection: Following your diagnosis with depression, your provider will discuss a range of available options, including medications. If an antidepressant is chosen, your provider and you will jointly decide on what antidepressant would work best for your after considering the following:

  • Your current symptoms.
  • Your past history with antidepressants.
  • The anticipated effectiveness of the antidepressant in your case.
  • Tolerability – the degree to which you can tolerate adverse effects of the antidepressant.
  • Safety – the risk in terms of clinical adverse events that you are exposed to due to the antidepressant as assessed by physical examination or laboratory testing.
  • Affordability.

Step 3: Monitoring outcomes and adjusting medication: This is the heart of measurement-based care and involves measuring the following four parameters:

a. Depressive symptoms severity using tools such as the PHQ-9.
b. Tolerability:  A commonly used tool is the self-reported Frequency, Intensity, and Burden of Side Effects Rating (FIBSER) (Wisniewski et al., 2006).
c. Adherence to antidepressant treatment: A simple 4-item questionnaire, Morisky Medication Adherence Scale (MMAS-4), can be used to assess adherence (Morisky et al., 1986). The items include:
  • Do you ever forget to take your medicine?
  • Are you careless at times about taking your medicine?
  • Sometimes if you feel worse when you take the medicine, do you stop taking it?
  • When you feel better do you sometimes stop taking your medicine?

d. Safety: Safety is assessed based on monitoring for the emergence of any events listed as black-box warnings or other warnings and precautions, or commonly reported adverse events as listed in the FDA-approved prescribing information for the particular medication.

Measurement-based care helps a provider determine if an individual with depression has received an adequate antidepressant trial or not. If an individual has had 26-49% reduction in their depressive symptoms, then their response to the antidepressant is considered a partial response. The next logical step guided by measurement-based care is to assess for tolerability and safety and if there are no issues with these, then the next step would be to increase the dose of the antidepressant roughly every 2 weeks until a minimum therapeutic dose has been reached or until one achieves remission (Morris et al., 2012). Other strategies such as augmentation with other non-antidepressant medications may be also tried in partial response. Similarly, non-response (less than or equal to 25% reduction in symptoms) would trigger a change in medication after an adequate trial with an antidepressant.

Step 4: Long-term monitoring and maintenance: Here the goal of treatment is remission and return to previous functioning levels. Two questions that are addressed in this step are:

  • What to do if the antidepressant stops working?
  • When should the antidepressant be stopped after a period of sustained remission?

While advocating for yourself, insist that your provider follow a paradigm of measurement-based care for treating your depression. A study showed that compared to individuals receiving standard care, those receiving measurement-based care are more likely to achieve greater response and remission rates (Guo et al., 2015). This study also found that individuals receiving standard care were on lower dosage of antidepressants compared to individuals receiving measurement-based care. Thus, measurement-based care ensures that you are receiving an antidepressant at an adequate dose and are not stuck at a low sub-therapeutic dose. It also ensures that you are tolerating the antidepressant well without any safety issues, that you are adhering with the treatment regimen, and that the treatment regimen is changed if the response is inadequate. The period between 1 and 3 months after starting an antidepressant may be most critical for fine-tuning the antidepressants, which may yield faster and better outcome (Guo et al., 2015).



Guo, T., Xiang, Y. T., Xiao, L., Hu, C. Q., Chiu, H. F. K., Ungvari, G. S., Correll, C. U., Lai, K. Y. C., Feng, L., Geng, Y., Feng, Y., & Wang, G. (2015). Measurement-based care versus standard care for major depression: a randomized controlled trial with blind raters. American Journal of Psychiatry, 172(10), 1004-1013.

Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67-74.

Morris, D. W., Toups, M., & Trivedi, M. H. (2012). Measurement-based care in the treatment of clinical depression. FOCUS, X(4), 428-433.

Wisniewski, S. R., Rush, A. J., Balasubramani, G. K., Trivedi, M. H., Nierenberg, A. A., & STAR-D Investigators. (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice, 12(2), 71-79.


Popular posts from this blog

Self-Management: A New and Proven Way to Treat Depression

What is self-management?
You probably have heard the term “self-help” and may have also read a few self-help books. Most self-help books on depression focus on acute treatment of depression based on a particular model of therapy, usually the Cognitive-Behavioral Therapy (CBT). While the self-help approach tries to address a condition using a focused treatment modality over a short period of time, self-management is learning new ways to manage an illness over a longer period of time. In other words, self-management is using the resources and learning the skills to “positively manage” an illness (Lorig et al., 2006). Lorig and colleagues (2006) further elaborate on self-management; it is a “management style” wherein you are a positive self-manager who not only uses the best treatments provided by healthcare professionals, but also approach your illness in a proactive manner on a daily basis, leading to a more healthy life. For example, good self-managers of diabetes, besides taking medic…

Procrastination in Depression: The Motivation Myth

Procrastination is putting off things for another day, or doing things which are not productive as an excuse of not doing what is important. Dr. Wayne Dyer (1995) in his book, Your Erroneous Zones, provides the rationale behind procrastination as a thought process which is something like this: “I know I must do that, but I am really afraid that I might not do it well, or I won’t like it. So, I will tell myself that I will do it in the future, then I don’t have to admit to myself that I am not going to do it. And it is easier to accept myself this way.” This temporary avoidance gives you a quick relief from the anxiety associated with a task, which then reinforces this behavior. We all have procrastinated at one time or the other, but in depression, procrastination becomes more complex due to the self-defeating attitudes of perfectionism (“I can do things only if I can do them perfectly”), hopelessness (“My low motivation and low energy levels are never going get better”), and fear of …

The “ABCDE” Behaviors that Derail Relationships When You are Feeling Depressed

The acronym “ABCDE” refers to certain types of communication behaviors that increase conflict and marital/intimate relationship distress. These behaviors get heightened when one is depressed as depression rekindles negative irrational thought patterns such as all-or-none thinking, overgeneralization,  jumping to conclusions, blowing things out of proportion, taking things personally, disqualifying positives, and negatively labeling self or others. Here's what you need to avoid during communication with your partner (Beach et al., 1998; Christensen et al., 2014; Starr & Davila, 2008):
Accusation: Accusations usually are “You always …” or “You never…” statements. Accusations may have some kernel of truth in them, but that gets exaggerated and dramatized by the heat of the argument. Accusations lead to counteraccusations and defensiveness and takes away the focus from one’s own shortcomings and also from resolving the conflict on hand.
Blame: Individuals may blame their partner’s …